Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07342296 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Pituitary Adenylate Cyclase Activating Polypeptide-38 (PACAP-38) is a key neuropeptide in migraine pathophysiology and treatment. This study investigates whether PACAP-38 administration can trigger aura in individuals with a diagnosis of migraine with aura.
Trial Details
NCT Number NCT07342296
Lead Sponsor Danish Headache Center
Conditions
(from sponsor)		 Migraine With Aura, Migraine Aura
Related terms Epilepsy, Migraine Disorders, Migraine with Aura
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov